Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120433) titled 'A prospective, observational, multicenter study to evaluate the efficacy of ultrafine particle triple therapy on lung function in Chinese patients with chronic obstructive pulmonary disease' on March 13.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Peking University Third Hospital
Condition:
Chronic Obstructive Pulmonary Disease (COPD)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-26
Target Sample Size: Beclometasone/Formoterol/Glycopyrronium treatment group:340;
Countries of Recruitment:
China
To know more, visit https://www.chictr.or...